Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × moxonidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Cyclophosphamide 1710 Radiotherapy 1566 Cisplatin 1504 Carboplatin 1276 Gemcitabine 1189 Paclitaxel 1085 Bevacizumab 1043 Docetaxel 1029 pembrolizumab 1005 Capecitabine 962 Oxaliplatin 959 Fluorouracil 900 Dexamethasone 816 Rituximab 766 Nivolumab 761 Magnetic Resonance Spectroscopy 722 Etoposide 695 Doxorubicin 687 Drug Therapy 653 Radiosurgery 651 Irinotecan 644 Cytarabine 624 fludarabine 604 Leucovorin 567 Lenalidomide 514 fludarabine phosphate 467 Radiation 463 Temozolomide 460 Filgrastim 457 Cetuximab 446

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01504321 2018-11-02

Polycystic Ovary Syndrome - Improving Outcomes

Baker Heart and Diabetes Institute

Phase 4 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡